{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Luo Q"],"funding":["Ministry of Science and Technology of the People&apos;s Republic of China (CN)","Traditional Chinese Medicine International Scientific and Technological Cooperation Base of China"],"pagination":["485"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5674829"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["17(1)"],"pubmed_abstract":["<h4>Background</h4>Chinese herbal medicine formula Yu ping feng san (YPFS) is commonly used for allergic rhinitis (AR). Previous review had summarized the effectiveness and safety of YPFS, however without any subgroup analysis performed to provide detailed evidence for guiding clinical practice. YPFS was recommended for the management of AR by Chinese medicine clinical practice guideline, but the treatment duration of YPFS was also not specified. The aim of this study is to evaluate the effectiveness and safety of YPFS in treating adult AR with the most recent evidence, and attempt to specify the duration of utilisation through subgroup meta-analyses.<h4>Methods</h4>Seven databases were searched from their inceptions to September 2017. Randomized controlled trials (RCTs) evaluating YPFS fo"],"journal":["BMC complementary and alternative medicine"],"pubmed_title":["Potential effectiveness of Chinese herbal medicine Yu ping feng san for adult allergic rhinitis: a systematic review and meta-analysis of randomized controlled trials."],"pmcid":["PMC5674829"],"funding_grant_id":["2012DFA31760","GJZX2016019"],"pubmed_authors":["Zhang CS","Xue CC","Luo Q","Yang L","Guo X","Lu C","Zhang AL"],"additional_accession":[]},"is_claimable":false,"name":"Potential effectiveness of Chinese herbal medicine Yu ping feng san for adult allergic rhinitis: a systematic review and meta-analysis of randomized controlled trials.","description":"<h4>Background</h4>Chinese herbal medicine formula Yu ping feng san (YPFS) is commonly used for allergic rhinitis (AR). Previous review had summarized the effectiveness and safety of YPFS, however without any subgroup analysis performed to provide detailed evidence for guiding clinical practice. YPFS was recommended for the management of AR by Chinese medicine clinical practice guideline, but the treatment duration of YPFS was also not specified. The aim of this study is to evaluate the effectiveness and safety of YPFS in treating adult AR with the most recent evidence, and attempt to specify the duration of utilisation through subgroup meta-analyses.<h4>Methods</h4>Seven databases were searched from their inceptions to September 2017. Randomized controlled trials (RCTs) evaluating YPFS fo","dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Nov","modification":"2025-04-22T21:18:50.713Z","creation":"2019-03-27T03:01:06Z"},"accession":"S-EPMC5674829","cross_references":{"pubmed":["29110710"],"doi":["10.1186/s12906-017-1988-5"]}}